Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
13.25
-1.87 (-12.37%)
At close: Oct 17, 2025, 4:00 PM EDT
13.62
+0.37 (2.79%)
After-hours: Oct 17, 2025, 7:58 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $734.39 million as of October 17, 2025. Its market cap has increased by 70.98% in one year.
Market Cap
734.39M
Enterprise Value
689.52M
1-Year Change
70.98%
Ranking
Category
Stock Price
$13.25
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $734.39M, a decrease of -66.35%. That is a compound annual growth rate of -21.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 734.39M | 40.89% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.83B |
| Johnson & Johnson | 463.73B |
| AbbVie | 404.10B |
| UnitedHealth Group | 320.27B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 223.23B |